Prevalence of antimicrobial resistance in Helicobacter pylori isolates in Taiwan in relation to consumption of antimicrobial agents

International Journal of Antimicrobial Agents

Volumn 34, Issue 2, 2009, Pages 162-165

  Poon, Sek Kwong ^a   Lai, Chih Ho ^b   Chang, Chi Sen ^a,c   Lin, Wei Yu ^d   Chang, Yun Chieh ^d   Wang, Hung Jung ^d   Lin, Pao Hsuan ^e   Lin, Hwai Jeng ^f   Wang, Wen Ching ^d  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f Poh Ai Hospital   (Taiwan)

Author keywords

Antimicrobial consumption; Antimicrobial policy; Antimicrobial resistance; Helicobacter pylori

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG UTILIZATION; ERADICATION THERAPY; FEMALE; GASTROINTESTINAL DISEASE; GOVERNMENT REGULATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; TAIWAN;

ADULT; AGED; ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; TAIWAN; YOUNG ADULT;

EID: 67349100955     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.02.007     Document Type: Article

References (15)

1. Peek Jr. R.M., and Blaser M.J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2 (2002) 28-37
2. Van der Hulst R.W., Rauws E.A., Koycu B., Keller J.J., Bruno M.J., Tijssen J.G., et al. Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. Gastroenterology 113 (1997) 1082-1086
3. Hentschel E., Brandstatter G., Dragosics B., Hirschl A.M., Nemec H., Schutze K., et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 328 (1993) 308-312
4. Gu Q., Xia H.H., Wang J.D., Wong W.M., Chan A.O., Lai K.C., et al. Update on clarithromycin resistance in Helicobacter pylori in Hong Kong and its effect on clarithromycin-based triple therapy. Digestion 73 (2006) 101-106
5. Bochenek W.J., Peters S., Fraga P.D., Wang W., Mack M.E., Osato M.S., et al. Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies. Helicobacter 8 (2003) 626-642
6. Megraud F., and Lamouliatte H. Review article: the treatment of refractory Helicobacter pylori infection. Aliment Pharmacol Ther 17 (2003) 1333-1343
7. Ho M., Hsiung C.A., Yu H.T., Chi C.L., and Chang H.J. Changes before and after a policy to restrict antimicrobial usage in upper respiratory infections in Taiwan. Int J Antimicrob Agents 23 (2004) 438-445
8. Lai C.H., Kuo C.H., Chen P.Y., Poon S.K., Chang C.S., and Wang W.C. Association of antibiotic resistance and higher internalization activity in resistant Helicobacter pylori isolates. J Antimicrob Chemother 57 (2006) 466-471
9. Poon S.K., Chang C.S., Su J., Lai C.H., Yang C.C., Chen G.H., et al. Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies. Aliment Pharmacol Ther 16 (2002) 291-296
10. National Health Insurance Database. National Health Research Institutes; 2007. http://www.nhri.org.tw/nhird/en/index.htm [accessed 26 February 2007].
11. International classification of diseases, 9th rev. Clinical modification. 6th ed. Los Angeles, CA: Practice Management Information Corporation; 2004.
12. Hsueh P.R., Shyr J.M., and Wu J.J. Decreased erythromycin use after antimicrobial reimbursement restriction for undocumented bacterial upper respiratory tract infections significantly reduced erythromycin resistance in Streptococcus pyogenes in Taiwan. Clin Infect Dis 40 (2005) 903-905
13. Perez Aldana L., Kato M., Nakagawa S., Kawarasaki M., Nagasako T., Mizushima T., et al. The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance. Helicobacter 7 (2002) 306-309
14. Lopez-Brea M., Martinez M.J., Domingo D., and Alarcon T. A 9 year study of clarithromycin and metronidazole resistance in Helicobacter pylori from Spanish children. J Antimicrob Chemother 48 (2001) 295-297
15. Storskrubb T., Aro P., Ronkainen J., Wreiber K., Nyhlin H., Bolling-Sternevald E., et al. Antimicrobial susceptibility of Helicobacter pylori strains in a random adult Swedish population. Helicobacter 11 (2006) 224-230